Omega Diagnostics Group PLC (LSE:ODX) - Share price - Overview

Stock Report

Omega Diagnostics Group PLC ODX

Last Price
GBX21.33

Day Change
-0.42|-1.91%

As of 23/10/2017
08:26:59 BST | GBX
Minimum 15 Minutes Delay.

Last Close21.75p
Day Range21.33 - 21.33
Mkt Cap27.61Mil
52-Wk Range15.15 - 26.62
Yield %0.00
ISINGB00B1VCP282
Volume10,000
P/E28.07
P/S1.63
P/CF11.77

Share Price

Total Returns 20/10/2017

 Chg (%)  
More ...
Omega Diagnostics Group PLC-4.92 
FTSE 100 TR GBP3.64
 
Financials
201520162017
More ...
Income Statement
Turnover12.1112.7414.25
Operating Profit0.670.670.70
Net Profit0.740.570.71
Reported EPS0.700.500.70
Balance Sheet
Current Assets6.576.155.58
Non Current Assets16.0717.6320.18
Total Assets22.6423.7825.76
Current Liabilities1.971.771.92
Total Liabilities3.823.594.30
Total Equity18.8120.1921.46
Cash Flow
Operating Cash Flow1.251.251.92
Net Change in Cash-1.02-0.73-0.67
Broker Forecasts
Year EndingPre-taxEPSEPSgP/EPEGDPSYld %
More ...
'Broker Forecasts' provides consensus figures based on several brokers' views
20181.351.1348.0019.330.40--
20192.602.1086.6710.360.12--
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
19/07/2017PurchaseMr. David Evans18.001,111,111200,000.00
19/07/2017PurchaseMr. Andrew Shepherd18.00111,11120,000.00
19/07/2017PurchaseJag Grewal18.0053,3339,600.00
19/07/2017PurchaseMr. Colin King18.00277,77750,000.00

Company Profile

Omega Diagnostics Group PLC provides in-vitro diagnostics (IVD) products for use in hospitals, blood banks, clinics and laboratories and specializes in the areas of allergy and autoimmune, food intolerance and infectious diseases.

Sector

Medical Instruments & Supplies

Market Position

1283 of 1835 Companies

Index

FTSE AIM All Share

Outlook

(13/07/2017) ceo - "...We are all looking forward to a year of growth and further progress"

Next Event 21/11/2017

Next interim announcement
Ratios
CompSecMkt
More ...
PER (E)13.0521.2816.48
Div Yld (E)0.001.524.08
PEG (E)0.181.431.44
ROCE8.5319.5211.69
Op Mrgn4.899.49-23.26
EPS Grwth73.1225.4015.09
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00

Broker Sentiment

Strong Buy0
Buy0
Hold0
Sell0
Strong Sell0
  • Strong Sell
  • Strong Buy
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
More ...
Disclaimer
Directors
More ...
ChairmanMr. David Evans
Chief Executive OfficerMr. Andrew Shepherd
Finance Director & Company SecretaryMr. Kieron Harbinson
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.